Tectonic Therapeutic, Financials
| TECX Stock | 47.56 0.12 0.25% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.35 | 4.8606 |
|
|
The essential information of the day-to-day investment outlook for Tectonic Therapeutic, includes many different criteria found on its balance sheet. An individual investor should monitor Tectonic Therapeutic,'s cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tectonic Therapeutic,.
Net Income |
|
Tectonic | Select Account or Indicator |
Please note, the imprecision that can be found in Tectonic Therapeutic,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tectonic Therapeutic,. Check Tectonic Therapeutic,'s Beneish M Score to see the likelihood of Tectonic Therapeutic,'s management manipulating its earnings.
Tectonic Therapeutic, Stock Summary
Tectonic Therapeutic, competes with Fate Therapeutics, Caribou Biosciences, Arcus Biosciences, Karyopharm Therapeutics, and X4 Pharmaceuticals. Tectonic Therapeutic, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 05455M100 878972108 |
| Older Symbol | AVRO |
| Location | Massachusetts; U.S.A |
| Business Address | 490 Arsenal Way, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | tectonictx.com |
Tectonic Therapeutic, Key Financial Ratios
| EBITDA | (43.17 M) | ||||
| Net Income | (42.82 M) | ||||
| Book Value Per Share | 11.29 X | ||||
| Market Capitalization | 265.07 M | ||||
| Total Asset | 101.09 M |
Tectonic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tectonic Therapeutic,'s current stock value. Our valuation model uses many indicators to compare Tectonic Therapeutic, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tectonic Therapeutic, competition to find correlations between indicators driving Tectonic Therapeutic,'s intrinsic value. More Info.Tectonic Therapeutic, is rated third in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 0.18 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Tectonic Therapeutic, is roughly 5.66 . Common Stock Shares Outstanding is likely to rise to about 3.8 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tectonic Therapeutic,'s earnings, one of the primary drivers of an investment's value.Tectonic Therapeutic, Systematic Risk
Tectonic Therapeutic,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tectonic Therapeutic, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Tectonic Therapeutic, correlated with the market. If Beta is less than 0 Tectonic Therapeutic, generally moves in the opposite direction as compared to the market. If Tectonic Therapeutic, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tectonic Therapeutic, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tectonic Therapeutic, is generally in the same direction as the market. If Beta > 1 Tectonic Therapeutic, moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tectonic Therapeutic, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tectonic Therapeutic,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tectonic Therapeutic, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Tectonic Therapeutic, December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tectonic Therapeutic, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tectonic Therapeutic,. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tectonic Therapeutic, based on widely used predictive technical indicators. In general, we focus on analyzing Tectonic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tectonic Therapeutic,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 3.69 | |||
| Information Ratio | 0.2744 | |||
| Maximum Drawdown | 30.4 | |||
| Value At Risk | (6.50) | |||
| Potential Upside | 7.76 |
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.